Amarantus Bioscience Holdings Inc (AMBS)

[MagicCap]

Yes and much better results than GDNF at this stage, which was owned by a company purchased by Amgen for $250 mill at same stage. Amgen co founder Joseph Rubinfeld left Amgen in 1990 but he was familiar with GDNF and has callend MANF a potential blockbuster drug and said it could be the biggest success he has ever seen. He is a very well connected guy and is speaking about commercial opportunities for MAnF in other diseases on 1/8/13.

I believe he will help AMBS strike an in licensing deal and also get help them get substantial funding. I believe AMBS should be worth at least $75 mill right now (about 4 to 5 times current value).

Here is a good interview Rubinfeld did 10 yrs ago to give you a sense of what he brings to the table:
http://www.twst.com/interview/8279